Your browser doesn't support javascript.
loading
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.
Son, Jaekyoung; Lyssiotis, Costas A; Ying, Haoqiang; Wang, Xiaoxu; Hua, Sujun; Ligorio, Matteo; Perera, Rushika M; Ferrone, Cristina R; Mullarky, Edouard; Shyh-Chang, Ng; Kang, Ya'an; Fleming, Jason B; Bardeesy, Nabeel; Asara, John M; Haigis, Marcia C; DePinho, Ronald A; Cantley, Lewis C; Kimmelman, Alec C.
Affiliation
  • Son J; Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Nature ; 496(7443): 101-5, 2013 Apr 04.
Article in En | MEDLINE | ID: mdl-23535601

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Oncogene Protein p21(ras) / Proto-Oncogene Proteins / Ras Proteins / Metabolic Networks and Pathways / Glutamine Limits: Humans Language: En Journal: Nature Year: 2013 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Oncogene Protein p21(ras) / Proto-Oncogene Proteins / Ras Proteins / Metabolic Networks and Pathways / Glutamine Limits: Humans Language: En Journal: Nature Year: 2013 Type: Article Affiliation country: United States